Evotec
Company Snapshot
Founded: 1993
Entity Type: Public
Employees: 4,827
Region: U.S.
Revenue: $862.5 Millions
Revenue Year: 2024
Headquarter: Hamburg, Germany
Key Geographics: U.S., Germany, France, U.K., Switzerland, Rest of the World
Corporate Address: Essener Bogen 7 22419 Hamburg, Germany Tel. +49-40-560-81-0 www.evotec.com
Company Overview
Evotec SE operates as a drug discovery alliance and development partnership firm, focusing on discovering and developing small molecule drugs across diverse therapeutic areas. The company offers various drug discovery services, including target identification and validation, sample management, hit identification, in vitro pharmacology services, integrated CMC (Chemistry, Manufacturing, and Control), and proteomics services.
Financial Highlights (FY 2024)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Evotec In News
Company's Business Segments
- Shared R&D : It primarily includes drug discovery and development services and solutions.
- Just – Evotec Biologics : This segment is an advanced approach to designing, discovering, developing, and manufacturing modern bio-therapeutics and provides services in the areas of antibody molecular optimization, first-in-human integrated biologics, product and process design, continuous bioprocessing platforms, and commercial biomanufacturing.
Applications/End User Industries
- Non-Profit organizations
- Pharmaceuticals
- Healthcare
- Biotechnology
- Life Sciences
- Drug Discovery and Development
BCC Research Beacon 